In the past week, BRKR stock has gone up by 1.75%, with a monthly gain of 5.87% and a quarterly plunge of -5.24%. The volatility ratio for the week is 6.70%, and the volatility levels for the last 30 days are 4.27% for Bruker Corp The simple moving average for the past 20 days is -1.46% for BRKR’s stock, with a -10.25% simple moving average for the past 200 days.
Is It Worth Investing in Bruker Corp (NASDAQ: BRKR) Right Now?
The price-to-earnings ratio for Bruker Corp (NASDAQ: BRKR) is above average at 28.19x, Company’s 36-month beta value is 1.17.Analysts have differing opinions on the stock, with 7 analysts rating it as a “buy,” 3 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for BRKR is 102.99M, and currently, short sellers hold a 6.02% ratio of that floaft. The average trading volume of BRKR on January 23, 2025 was 1.47M shares.
BRKR) stock’s latest price update
Bruker Corp (NASDAQ: BRKR)’s stock price has dropped by -2.64 in relation to previous closing price of 60.12. Nevertheless, the company has seen a gain of 1.75% in its stock price over the last five trading days. seekingalpha.com reported 2025-01-19 that Bruker Corporation (NASDAQ: BRKR) is undervalued, trading below its fair value of $74, offering significant upside potential due to its strategic acquisitions and improving book value per share. Recent acquisitions enhance BRKR’s capabilities in high-growth markets like Life Sciences, Proteomics, and Spatial Biology, driving sustainable revenue growth and positioning the company for future demand. Despite current weaker EPS and operating margins, BRKR’s strong R&D investment and successful integration of acquisitions are expected to boost profitability and growth by FY2025.
Analysts’ Opinion of BRKR
Many brokerage firms have already submitted their reports for BRKR stocks, with Guggenheim repeating the rating for BRKR by listing it as a “Buy.” The predicted price for BRKR in the upcoming period, according to Guggenheim is $72 based on the research report published on December 19, 2024 of the previous year 2024.
UBS, on the other hand, stated in their research note that they expect to see BRKR reach a price target of $66. The rating they have provided for BRKR stocks is “Neutral” according to the report published on December 10th, 2024.
Goldman gave a rating of “Neutral” to BRKR, setting the target price at $60 in the report published on December 05th of the previous year.
BRKR Trading at 1.27% from the 50-Day Moving Average
After a stumble in the market that brought BRKR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.29% of loss for the given period.
Volatility was left at 4.27%, however, over the last 30 days, the volatility rate increased by 6.70%, as shares surge +2.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.46% lower at present.
During the last 5 trading sessions, BRKR rose by +1.51%, which changed the moving average for the period of 200-days by -35.41% in comparison to the 20-day moving average, which settled at $59.39. In addition, Bruker Corp saw -0.15% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BRKR starting from PACKER RICHARD A, who sale 3,350 shares at the price of $57.82 back on Dec 02 ’24. After this action, PACKER RICHARD A now owns 80,904 shares of Bruker Corp, valued at $193,683 using the latest closing price.
PACKER RICHARD A, the Director of Bruker Corp, proposed sale 3,350 shares at $57.82 during a trade that took place back on Dec 02 ’24, which means that PACKER RICHARD A is holding shares at $193,683 based on the most recent closing price.
Stock Fundamentals for BRKR
Current profitability levels for the company are sitting at:
- 0.1 for the present operating margin
- 0.49 for the gross margin
The net margin for Bruker Corp stands at 0.09. The total capital return value is set at 0.07. Equity return is now at value 20.22, with 6.14 for asset returns.
Based on Bruker Corp (BRKR), the company’s capital structure generated 0.56 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 1.26. The interest coverage ratio of the stock is 8.53.
Currently, EBITDA for the company is 599.0 million with net debt to EBITDA at 4.03. When we switch over and look at the enterprise to sales, we see a ratio of 3.39. The receivables turnover for the company is 6.02for trailing twelve months and the total asset turnover is 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.66.
Conclusion
In a nutshell, Bruker Corp (BRKR) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
